Over 1 in 250 Natal Girls Were Taking Testosterone By Age 17 in Oregon, From 2016 to 2023
open.substack.com/pub/benrya…
This rate, from a study of data about insured adolescents in Oregon, represents an average over this period. Given swift increases in hormone uptake over time, the rate was likely much higher by 2023.
The use of gender-transition drugs among adolescents in Oregon soared between 2016 and 2023, charting a nearly 10-fold increase among biological girls and a 14-fold increase in natal boys. Across this period, about 1 in 100 insured youth ages 8 to 17 in the Pacific Northwest state were diagnosed with gender dysphoria, a psychiatric condition involving distress stemming from a conflict between an individual’s natal sex and their gender identity.
By age 17, about 1 in 240 insured natal girls were taking testosterone and about 1 in 630 natal boys were taking estrogen in Oregon. These figures are nearly three-fold higher for natal girls and nearly twice as high for natal boys as figures from a study published last year that analyzed national data on commercially insured youth from 2018 to 2022.